Am J Health Syst Pharm. 2006;63(17):1641-1646. Our institution, the University of Virginia Health System (UVHS), added factor VIIa (recombinant) to its formulary on August 27, 1999. Informal ...
Factor VII's molecular mass of 50 kDa indicates that ... Uppsala, Sweden), and the active fractions collected in a 500 μl volume. The desalting buffer was 0.1 M HEPES/NaOH buffer, pH 7.4 and ...
Purpose. Unlabeled uses of factor VIIa (recombinant) in pediatric patients are reviewed. Summary. Factor VIIa (recombinant) is currently approved for the treatment and prevention of bleeding in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback